By monitoring GLP-1 prescriptions, obesity or diabetes management consultations, and other relevant diagnosis, procedure, and prescription claims, you can identify localized utilization trends, determine the financial impact of coverage changes in key networks or facilities, and identify high-value accounts for engagement
Long-term use of GLP-1 receptor agonists may elevate endogenous GLP-2 release, which further reduces antral motility
Ozempic for Weight Loss: Who Should Try It and Will It Work
These rules mirror Wegovy and Zepbound prescribing information
Patients with a BMI between 27 and 29.9 frequently ask whether they qualify
Label warnings to know: Thyroid C-cell tumor warning (avoid if personal/family history of medullary thyroid carcinoma or MEN2) Pancreatitis riskseek immediate care for severe abdominal pain Gallbladder disease Dehydration/acute kidney injury risk with persistent vomiting or diarrhea Drug interactions: Birth control (tirzepatide): Oral contraceptives may be less effective around initiation and each dose increase